PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers

NCT01205321 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Diagnostic Imaging

Interventions

DRUG: Bombesin (68Ga) labeled (BAY86-7548)
DRUG: Bombesin (68Ga) labeled (BAY86-7548)

Sponsor

Life Molecular Imaging SA